Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/01/17
End: 12/31/21
Due: 12/31/22
Phase: N/A
Priority: Normal
Start: 07/01/21
End: 12/31/24
Due: 12/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Efficacy and Adverse Effects of Nucleoside Analogues (TDF/LDT) in Preventing Mother-to-child Transmission of HBV | NCT03181607 | Xingfei Pan | user2@example.com | None | 2017-01-01 | 2021-12-31 | 2022-12-31 | - | - | 2025-07-14 |
| Safety and Efficacy of TAF to Prevent MTCT of HBV in Middle/Late Pregnancies With High HBV DNA Load | NCT05466071 | Xingfei Pan | user2@example.com | None | 2021-07-01 | 2024-12-31 | 2025-12-31 | - | - | 2025-07-14 |